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Abstract
Background: The risks of poor information transfer across healthcare settings are well documented, particularly for
medication. Various patient-held tools have been designed to hold information about patients’ medicines to
improve information transfer. Anecdotal evidence suggests some are more widely implemented than others,
but there has been little research exploring the reasons why. Our objectives were to explore the facilitators
and barriers to implementation of patient handheld medication information from the perspective of pharmacy
staff, to understand why some tools are more widely implemented than others and to make recommendations as
appropriate.
Method: Semi-structured interviews were conducted with 15 pharmacists and pharmacy technicians working in wards
and/or dispensary of a London hospital organisation. Participants were recruited using convenience sampling.
We asked about six purposefully selected tools designed to be carried by patients to provide information
about their medicines, including both national and local tools, and those that were new and established.
Interviews were audio-recorded and transcribed verbatim. We used framework analysis, based on a theory of
behavioural change.
Results: The majority of participants expressed the view that older tools, such as the steroid card and warfarin booklet,
were used more often than newer tools such as a medication passport and a specific insulin passport. Interview data
suggested that pharmacy staff did not have enough information and training about the proper use of the newer tools
and therefore lacked confidence in providing them to their patients. In addition, they perceived that they were not
integrated into policies and procedures with a lack of guidance regarding their use.
Conclusion: We identified the main barriers to effective implementation of tools to increase patient safety
across healthcare settings to be lack of guidance and training for newer tools. Making a tool available is not
sufficient to ensure its use. Recommendations include clarifying guidance within the hospital organisation to
standardise use of all tools and raising awareness and providing training to both healthcare professionals and
patients about their use.
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Background
The risks of poor information transfer across health care
settings are well documented, particularly for medica-
tions [1]. It has been estimated that up to 60% of
patients admitted to hospitals have at least one discrep-
ancy on their admission drug history [2]. While there
are relatively few UK studies, in March 2007, the Na-
tional Reporting and Learning System for England and
Wales reported 7070 medication errors involving admis-
sion and discharge, including two fatalities and 30 cases
of severe harm [3]. Empirical studies suggest that in the
hospital setting, prescribing errors are most likely to
occur at the time of admission, largely due to challenges
of medication reconciliation [4, 5]. An audit of more
than 8600 patients across 50 acute hospital trusts found
that when medicines were checked after admission, most
patients had at least one drug omitted or prescribed with
the wrong dose [6]. Earlier estimates suggested that 30
to 70% of patients have either an error or an uninten-
tional change to their medicines when admitted to hos-
pital [3]. Problems are also common following transfer
from hospital into the community [7, 8] and when at-
tending outpatient appointments [9]. A survey com-
pleted by 1133 London general practitioners to identify
priorities for improvement of medication safety in pri-
mary care identified incomplete reconciliation of medi-
cation as the highest priority [9].
Increasing patient and carer involvement with their
medication records is a potential approach to improv-
ing information transfer across settings. Several
paper-based documents are available for use in the
UK to be carried by patients to provide information
about their medicines. One is “My Medication Pass-
port” (MMP) [10], used to record details of the pa-
tient’s medications. Others are used for specific
medications such as insulin, corticosteroids, warfarin
and other anticoagulants. Such tools are often sup-
plied by pharmacy staff with the dispensed medicine
and are intended to help patients and carers to com-
municate details of their medication to other health-
care professionals as well as providing important
information for the patients themselves.
Previous studies suggest that many patients bring
some information about their medicines to hospital, al-
though this is rarely a formal document [1, 10, 11].
However, research in this area is limited. Two previous
studies have focused on MMP [10, 11] and another doc-
umented the information that patients brought into hos-
pital [1] without exploring its use in more detail. While
the two studies on MMP yielded some information on
its use, they were limited to a case study [11] and tele-
phone interviews [10] to find out whether patients had
used their passport, with whom they had shared it and
their suggestions for improvement.
Local anecdotal evidence suggests that some tools are
more widely implemented than others. Most of the avail-
able literature on handheld medication information tools
was based on the patient’s point of view [10, 11]. The
aim of this study was to explore the facilitators and bar-
riers to the implementation of patient handheld medica-
tion information tools from the perspective of pharmacy
staff. We sought to understand why are some may be
more widely implemented than others and to make rec-
ommendations to improve their implementation and en-
hance patient safety. Pharmacy staff were chosen as they
supply most of the handheld medication information
tools as part of the medication safety program.
Methods
Study design
Semi-structured interviews with pharmacy staff (see
Appendix for interview guide).
Setting
The study was carried out at a hospital organisation in
London with three main sites. Pharmacy staff in the or-
ganisation provided a range of clinical services including
medicines reconciliation, medication review, attendance
on some ward rounds, checking discharge prescriptions
for appropriateness and carrying out patient consulta-
tions in some outpatient clinics. Inpatient and discharge
medication was supplied by the pharmacy department,
which also provided a medicines information service.
Tools
We evaluated six different handheld medication infor-
mation tools (Table 1): (1) MMP [10], (2) the insulin
passport [12], (3) the warfarin ‘yellow booklet’ [13], (4)
alert cards for direct oral anticoagulants [14, 15], (5) the
steroid card [16] and (6) a locally produced medicines
helpline card given out with discharge medication [17].
These were chosen purposively to include both local
(medicines helpline card) and national tools (the insulin
passport [12], the warfarin ‘yellow booklet’ [13], anti-
coagulant alert cards [14, 15], the steroid card [16] and
the MMP [10]) and to include those that had been re-
cently implemented (insulin passport introduced in 2012
and MMP and anticoagulant alert cards in 2013) and
those that had been in place for some time (steroid card
and medicines helpline card in use since the mid-1990s,
yellow warfarin booklet in place at least 25 years). All
tools are available free of charge at the point of use.
Sampling strategy
The researchers aimed to interview 15–20 pharmacists
and pharmacy technicians working on wards and/or in
the dispensary. The pharmacists were recruited based on
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purposive sampling to include different genders and
grades of staff.
Recruitment
The researcher recruited pharmacists and pharmacy
technicians through attending clinical pharmacy meet-
ings held weekly at the three hospitals. Pharmacists and
pharmacy technicians identified as potential participants
were then contacted, either by e-mail or in person, to ar-
range an interview. The recruited participants were not
previously known to the researcher. They were informed
that the researcher was carrying out the project as part
of a master’s degree.
Data collection process
Data collection took place between 24 May and 17 June
2016. Potential participants were given an information leaf-
let and invited to give informed consent. Semi-structured
interviews were conducted face-to-face, audio-recorded
and transcribed verbatim. TW, a pharmacy student placed
at this hospital trust to complete clinical training and re-
search as part of her master’s degree, conducted the inter-
views. Each participant was interviewed once, and no one
else was present besides the researcher and the interviewer.
Topic guide
The topic guide was developed by the researchers and
piloted prior to the study. During the interviews, partici-
pants were first asked about each tool separately. They
were asked to describe both the facilitators and the bar-
riers to their implementation and what might prompt
them, or prevent them, from giving them to patients.
They were also asked about what healthcare profes-
sionals could do to improve their implementation and
why they perceived that some were implemented more
than others (see Appendix for interview guide). The
transcripts were not returned to participants for com-
ments, correction or feedback on the findings.
Data analysis
Interview data were categorised and coded using frame-
work analysis, for which we selected Michie et al.’s [18]
behavioural change framework to explore the process of
behaviour change as applied to implementation. The
framework comprises 12 domains: (1) beliefs about cap-
abilities; (2) knowledge; (3) emotion; (4) environmental
context and resources; (5) skills; (6) nature of the behav-
iour; (7) social professional role; (8) social influence; (9)
behavioural regulation; (10) beliefs about consequences;
(11) memory, attention and decision processes; and (12)
motivation and goals. All transcribed data were entered
into QRS NVivo computer software [QSR International,
Victoria, Australia, version 11], which enabled organisa-
tion, indexing, sorting and retrieval of the data. The
interview data were viewed and analysed by two re-
searchers who agreed on the final themes identified.
Ethical considerations
The study was approved as a service evaluation at the
hospital organisation.
Results
Thirteen pharmacists and two pharmacy technicians agreed
to take part, most of whom (n = 12) were female. All except
one pharmacist worked full time. Participants’ characteris-
tics are summarised in Table 2. Although a purposive sam-
ple was sought, the final sample was influenced by
convenience, to some extent, as it depended who was avail-
able and willing to take part. The duration of interviews
ranged from 15 to 40min, with a mean duration of 27min.
Extent of implementation
The majority of participants perceived that the steroid
card, warfarin yellow booklet, anticoagulant alert cards
and medication helpline card were widely implemented.
"I think they’re implemented very well. I’ve seen about
100% of all patients on anticoagulants having either
an alert card or an anticoagulation yellow book. Every
Table 1 Description of tools
Tool Description Year implemented Local or national
MMP Allows documentation of personal details of the patient as well as their
past and current medication.
2013 National
Insulin passport Allows documentation of personal details of the patient as well as the
type and dose of insulin.
2012 National
Warfarin yellow booklet Allows documentation of personal details of the patient as well as their
daily dosage of warfarin.
Almost 25 years ago. National
Alert card Allows documentation of personal details of the patient as well as
information on the use of anticoagulant medication and warning signs.
2013 National
Steroid card Allows documentation of personal details of the patient as well as details
of their corticosteroid treatment.
Mid-1990s National
Medicine helpline card Provides the medicines helpline number for medicines information. Mid-1990s Local
Waly et al. Safety in Health            (2018) 4:13 Page 3 of 12
single patient who’s on warfarin is counselled very
well here and every single patient is given a yellow
book. Similarly, for the alert cards." (Acute admissions
ward pharmacist)
"The steroid card and the medicines helpline card are
used to 100% and are fully implemented."
(Nephrology ward pharmacist)
In contrast, the vast majority of participants were of
the view that MMP and the insulin passport were not
widely implemented:
"My Medication Passport! So, I don’t see it a lot. I
have rarely seen it with returning patients." (Pharmacy
technician 2)
"I think maybe once in my life I have seen a patient
with an insulin passport, if even that, so I don’t think
it’s very widely implemented." (Major trauma ward
pharmacist)
Factors affecting implementation: using Michie et al.’s
behavioural change framework
Table 3 illustrates the mapping of codes to the 12 psycho-
logical domains, each of which are next presented in turn:
Beliefs about capabilities
Pharmacist’s capabilities (self-confidence/professional
confidence) Some participants were of the view that
they did not have enough confidence to provide MMP
and the insulin passport.
"So, for instance, the Insulin Passport and the
Medication Passport, because they are not really part
of any procedures and because, in the grand scheme
of it, they are relatively new, I think people are still
not very confident or they are not – it’s not at the
forefront of their mind to use them or to promote
them. So they are not used as much, from my own
personal experience." (Pharmacy technician 2)
Pharmacists’ perceptions of patients’ capabilities
(How capable are they of maintaining/how difficult is
it for them to do it?): It became apparent from the ana-
lysis that the anticoagulant alert cards, steroid alert
cards, warfarin yellow books and steroid cards were seen
as needing less involvement from patients than the medica-
tion passport and insulin passport. For the former tools, pa-
tients needed to understand that they have to carry them
around. However, for the latter, patients needed to have
more input in terms of filling them in and keeping them up
to date, and interview data suggested that both perceived
high and low patient capability could be a barrier. Patients
perceived to have good ability to manage their medicines
were not perceived to need additional tools, and patients
with low ability to manage their own medicines were
viewed as being unable to use the tools provided. There
were therefore only a small number of patients for whom
these tools were perceived to be helpful.
"For patients that are longstanding on diabetic
medication I probably would assume they don’t
require one." (Rotational pharmacist 1)
"Sometimes these patients forget to take their
medicines, never mind write them all down very
accurately on this card alongside other… There’s
about 50 fields of information that need to be filled
out here. So, you know, I don’t see it too widely
used." (Major trauma ward pharmacist)
In addition, participants were of the view that the MMP
and insulin passport were useful only for patients man-
aging their own medication, not those who were having
their medicines managed by carers. It was also noted that
many of the tools were only available in English and there-
fore could not be used by those proficient in this language.
Knowledge: (knowledge about the tool/procedural knowledge)
Interview data suggested that pharmacists had differen-
tial knowledge of the different tools.
Some pharmacists reported that they did not know the
procedure as to whom they should supply with an MMP
and at what stage they should supply it.
"I personally wouldn’t really know when to give it [My
Medication Passport] out or at what stage, or whether
it’s given out already, whether it’s something I should
Table 2 Description of participants
Role Site Male Female Total
Independent prescriber Hospital 1 1 1
Nephrology ward pharmacists Hospital 1 1 1
Emergency and elderly medicines1 Hospital 2 1 1
Rotational Pharmacists Hospital 2 3 3
Pharmacy technician 1 Hospital 2 1 1
Discharge pharmacist Hospital 2 2 2
Pharmacy technician 2 Hospital 3 1 1
Part time rotational pharmacist Hospital 3 1 1
Acute admission ward pharmacist Hospital 3 1 1
Emergency and elderly medicines 2 Hospital 3 1 1
Rotational pharmacists 4 Hospital 3 1 1
Major trauma ward Hospital 3 1 1
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ask the patient for when they come back in, or whether
it’s given at discharge." (Part-time rotational
pharmacist)
In contrast, participants reported that they had good
knowledge of other tools such as the steroid card and
yellow booklet.
"[The steroid card] is the type of thing that you are
taught about when you first learn what steroids are."
(Rotational pharmacist 1)
Emotion: (how does emotion affect implementation?)
Participants rarely raised emotions as being a factor affect-
ing implementation of handheld medication information.
However, one participant described pharmacy ‘passion’ as
an emotion that would facilitate implementation and
another was of the opinion that patients’ frustration would
be a barrier.
Environmental context and resources: (to what extent do
physical or resource factors facilitate or hinder?)
Many of the barriers identified feed into this category; these
have been grouped into availability of tools, their design,
transfer of patients between wards and time restrictions.
Availability of tools Respondents indicated that some
of tools were more easily available in the dispensary than
others. The steroid card, warfarin yellow booklet and
medicines helpline or information card were reported as
being readily available, whereas MMP and insulin pass-
ports were sometimes in low supply.
"The medicines information card is always used, we
see it all the time in the dispensary, there’s big piles of
Table 3 Matching between domains and codes
Domains Sub-domain (for some of the domains) Codes
1. Beliefs about capabilities Pharmacists’ capabilities Self-efficacy of the pharmacists
Pharmacists perception of patients’ capabilities Ability to manage their own medicine
Having a carer
2. Knowledge Pharmacists’ knowledge about the tools and the
procedure
Level of knowledge
3. Emotion Pharmacists’ feelings
Patients’ feelings
4. Environmental context and resources
(environmental constraints)
Factors related to the tools Availability of handheld medication records
Design of handheld medication records
Factors relating to the hospital environment Relocation of patients
Time limitations
5. Skills Pharmacists’ skills Level of pharmacist skill required
6. Nature of the behaviour Pharmacists’ behaviour towards the tools Standard operating procedures
7. Social, professional role Pharmacists beliefs about responsibility Pharmacists’ role
Other healthcare professionals’
responsibility
8. Social influence (norms) Importance of patients feedback Patients’ feedback
Pharmacy feedback
Interprofessional communication
Establishment of practice
9. Behavioural regulation Methods needed to encourage pharmacist to effective
implementation
Advertisement
Audits
Training
10. Beliefs about consequences (anticipated
outcomes attitude)
Beliefs about risks High-risk drugs.
Polypharmacy
11. Memory, attention and decision
process
Factors affecting the pharmacists’ and pharmacy technicians
attention and decision making
Forgetfulness
12. Motivation and goals (intention) Methods to motivate pharmacists Pay pharmacists to provide it
The 12 domains are from Michie et al. behavioural change framework [18] and the sub-domains were identified from our data
Waly et al. Safety in Health            (2018) 4:13 Page 5 of 12
them in dispensary and we always give them out.
Same with the steroid cards as well, that’s something
that we always give out. Warfarin as well, that’s
something that we always give out as well."
(Pharmacist technician 2)
"A big barrier initially was that we just didn’t have
any. So we kept being told about the insulin passport
but then we couldn’t actually get them from
anywhere. It seemed to take a long time to actually
have any stock or reliable stock." (Independent
prescriber)
Even for those tools where the supply was plentiful, par-
ticipants reported that their availability on wards was lower,
resulting in their being unable to issue them while they
were with a patient unless they had brought a supply with
them. The unavailability of medicines helpline cards on the
wards also acted as a barrier to other healthcare profes-
sionals issuing them. This was of particular relevance where
discharge medication was given from prepacks stored on
the wards rather than being assembled in the pharmacy.
"Just having them available on the ward maybe. So
nurses could added it into their bags if its not there.
Because again we sometimes assemble the TTAs [to take
away medication] on the wards. So, it’s not always
coming from the pharmacy. when the nurses are
assembling it, they could simply add it." (Rotational
pharmacist 2)
Design of tools Participants identified design problems
with some of the tools: the MMP was reported to be too
bulky and to not have a user-friendly design and layout
as it was not pocket-sized. The trifold nature of the insu-
lin passport was also reported to be unmanageable. The
medicines helpline card was reported to be so small that
it could be lost and the steroid card to be outdated. In
contrast, the warfarin yellow booklet was perceived to be
well designed. In general, pocket-sized medication infor-
mation was considered preferable.
"I think particularly for male patients who don’t
always carry a bag, you know, it’s not so easy to put
some of these in your pocket, they’re not of
insubstantial size." (Independent prescribing
pharmacist)
Patient transfer Participants indicated that providing
patients with tools was challenging when patients were
transferred to other wards, as the pharmacist would be
unable to go and find them before they were discharged.
"By the time I get round to it, they’ve moved off, so
they’re not on my ward any more, they’re not within
my service to be able to…I can’t go and find them,
they might have moved to a medical ward, they might
have gone home already." (Emergency and elderly
medicine ward pharmacist 1).
Time limitations The vast majority of participants iden-
tified time as a barrier. While this was the case for all
the tools, this was most frequently raised as a barrier for
the insulin passport and MMP. These two tools were
thought to need a lot of education from the pharmacy
staff to the patient for effective implementation.
"Especially, I’ve found, with the Medication Passport.
Unless you explain how it works, there’s no point in
giving it to someone. So I think they have the
potential to be really, really beneficial, but along with
just giving it to a patient, you have to have that
education to go with it. That’s just the part that’s
more time-consuming and just needs a bit more work
on, I think." (Acute admission ward pharmacist).
Skills
Skill level was rarely raised by participants as a factor af-
fecting implementation. However, one participant
expressed the view that the steroid card was a much
simpler tool to implement than MMP and could be
actioned by a relatively inexperienced member of staff.
"It’s a very simple sort of a card I suppose as well; it
doesn’t require a lot of input. In fact, some of the only
input it requires is for someone to stick a label on it;
the label can easily be issued twice by just changing
the, sort of, profiles of drug and [pharmacy dispensing
system]. You ask [pharmacy dispensing system] to
issue two new labels, that’s the other prompt with a
dispenser who could be a Band 2 [pharmacy assistant
with little formal training] for all we know, that this
medicine requires a steroid card." (Major trauma ward
pharmacist)
Nature of the behaviour: (routine/automatic/habit)
Participants expressed the view that tools would be more
widely implemented if they were integrated into stand-
ard operating procedures (SOPs). The yellow warfarin
booklet, steroid cards and the medicines helpline card
were all described as being incorporated into hospital
procedures. Some participants were also of the view that
the insulin passport and new anticoagulant alert cards
were embedded into SOPs, whereas others were not. No
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participants expressed the view that the MMP was part
of SOPs and some participants specifically stated that it
was not.
"Well some are ingrained into us through standard
operating procedures. And others are more… So for
example the steroid, the helpline, that’s all ingrained
into us in SOPs. However, the medication passport is
more if you think the patient needs it then it’s at the
discretion of either their ward based technician or the
pharmacist once they’ve spoken to the patient."
(Nephrology ward pharmacist)
Social, professional role
Interview data suggested that some tools were seen as a
core part of a pharmacist’s role, whereas others were seen
as ‘medicines management’ and something that could be
taken on by other healthcare professionals. For example,
the variable dosing of warfarin dependent on the inter-
national normalised ratio meant that the warfarin yellow
booklet provided information about the dosage, which
would not be on the medication label and this was there-
fore seen as an essential clinical process. Likewise, steroid
alert cards were seen as essential as the requirement to
issue these is specified in the BNF [British National
Formulary]. However, the MMP and insulin passport
were seen as medication management tools. Partici-
pants were of the view that issuing the MMP was
seen as a pharmacy role, but this should not neces-
sarily be the case. Some participants discussed the
specialised diabetes nurse as the person who had the
role of providing the insulin passport.
"So all of our anti-coagulation…it’s the job of the pharma-
cist to make sure they get it, and because that’s part of
our role and our safety role, I think the implementation
of those are probably one of the best, and then as you go
down, you have to seek patients to implement My Medi-
cation Passport currently, it’s not offered to everyone."
(Emergency and elderly ward pharmacist 1)
"There is a feeling that it’s (the steroid card) a clinical
issue. I think sometimes in pharmacy there are things
that are medicine management issues that are treated
differently to things that are considered clinical issues.
Medicines management are … sometimes I think goes
by the wayside." (Pharmacy technician 1)
"Maybe involving the nurses a bit more into the
different passports that we have and then they can
identify patients that are suitable as well as us. And
hand them out as they see fit. It doesn’t have to just
be pharmacists. It’s not really a clinical intervention.
It’s just information for the patient." (Rotational
pharmacist 1)
Social influence: (team working/feedback)
Some participants reported that they were interested in
getting feedback from patients who were issued with the
MMP, the insulin passport or the steroid card. Another
participant was of the opinion that healthcare profes-
sionals should have the opportunity to feed back about
the handheld tools. It became apparent from the analysis
that inter-professional communication was also an issue
in terms of handovers and ensuring that all healthcare
professionals knew when a member of pharmacy staff
had identified that a patient would benefit from a given
tool.
Behavioural regulation: (are there procedures or ways of
working that would encourage implementation?)
Findings in this area relate to raising awareness, audits
and training.
Awareness raising Participants were of the view that
raising awareness of some of the handheld medication
information, especially the newer ones such as the MMP
and the insulin passport, might encourage wider imple-
mentation. Advertisements could be to pharmacy staff,
other healthcare professionals or directly to patients.
One participant thought that patients could be used a
direct mode of advertising to others.
"Teaching sessions, posters, just like highlighting
medication passports. I think in my old trust we had
a poster for nurses so they were aware of it so
sometimes you’d get a phone call from one of them
being like, 'We need one'." (Discharge pharmacist)
Audits Two participants believed that organising regular
audits on the use of the handheld medication informa-
tion might encourage more healthcare professionals to
provide them to their patients.
"Regular audits to see how much use of these cards
is helping patients and how much it’s being used.
Providing feedback on these audits so that different
departments can help facilitate the use of them more.
So, by giving feedback, we can develop strategies to
perhaps use them more, if that makes sense." (Acute
Admission ward Pharmacist)
Training Participants were of the view that training staff
and patients would facilitate implementation. Participants
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differentiated between the training that was in place for
the warfarin yellow booklet and steroids and that available
for other tools, such as the MMP, insulin passport and
medicines helpline card.
"I don’t really feel that, apart from the warfarin, and
also maybe the steroid cards, there’s no real set way
or I’ve never been trained in being, ‘So this is a
Medicines Passport, this is how we should be
promoting them.’ There’s never been a set, ‘Oh, with
Medicines Passports, make sure you say this with a
patient.’And that may be something useful coming
from the people who are producing them. Because if
they want to promote these, then they should be
having a set list of things that they want us to push
through as healthcare professionals." (Major Trauma
ward pharmacist)
Beliefs about consequences (anticipated outcomes)
Participants were of the view that high-risk drugs or sit-
uations would prompt them to offer the tools to pa-
tients. Anticoagulants, steroids and insulin were
identified as high-risk drugs. However, while this meant
that the warfarin booklet, anticoagulant alert cards and
steroid card were widely implemented, this was not ne-
cessarily the case for the insulin passport, suggesting
that beliefs about consequences may only facilitate im-
plementation if other factors are also present.
"They’re high risk drugs. They’re associated with
significant harm if not taken appropriately. So I
suspect that’s why we issue the alert cards for steroids
and warfarin, and now for insulin, because of the risks
associated with it. So I suppose drugs which are
associated with high risks contribute to the
implementation of these things. … The insulin
passport is a newer initiative, and I think the reason
why it’s been introduced is because of the risks which
have occurred where patients are inadvertently taking
incorrect insulin. […] Although it’s important, I
suppose the awareness needs to be upped a lot more
in a similar way to the warfarin and the steroid
booklets." (Part-time rotational pharmacist)
Similarly, two participants expressed the view that
polypharmacy would be a prompting factor to offer pa-
tients an MMP.
"In particular, we need to identify those patients
who have quite a few drugs and often may involve
quite a few changes in their medications when
they’re transferred from GP to hospital." (Rotational
pharmacist 3)
Memory, attention and decision process
Issues related to forgetfulness were raised as barriers to
implementation of all the tools apart from the yellow
warfarin booklet. However, while forgetfulness was
raised for a whole range of tools, participants were of
the view that the newer tools including the insulin pass-
port, the MMP and the newer anticoagulant alert cards
had not become part of a habit-forming process and
were therefore less likely to be issued.
"As part of the drug history we don’t routinely ask
them, and that might just be habit, and we haven’t
developed it into a habit when we ask them about
their insulin. I don’t ask them about a passport."
(Rotational pharmacist 1)
Motivation and goals (intention)
Issues related to motivation and goals were rarely raised
by participants. However, one pharmacist suggested that
one way of encouraging pharmacists to provide the
MMP was to pay them for issuing it.
"They could probably attribute a cost to the
anticipated days saved or something of a hospital
duration if everyone in the NHS came into hospital
with a medication passport. So if that cleared up all
sorts of medication incidents that prolonged hospital
admission, attribute a cost to that, then pass that cost
or saving potentially on to the trust with CQUINs
[Commissioning for Quality and Innovations
incentives] or incentives or giving helpful pharmacists
like myself £5 every time they issued one to a patient."
(Major Trauma ward pharmacist).
Discussion
The steroid card, yellow warfarin booklet, anticoagulant
alert cards and medicines helpline card were reported to
be much more widely implemented than the insulin
passport and MMP. This is in agreement with the study
by Walkers and Wilcock [19] that has demonstrated
poor implementation of the insulin passport, with only
4% of patients bringing a complete passport with them
into hospital and only third of the total patients having
actually heard of them. Findings suggest that the main
reasons for these differences in implementation were
that the former tools have been part of both the SOPs at
the hospital organisation and pharmacy staff education
and training. Participants were of the view that the
high-risk medications such as the anticoagulants and the
steroids facilitated distribution of some associated tools.
However, this was not reported to be the case with the
newer tools, even for higher risk medication (insulin).
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Participants expressed uncertainty about whether issuing
an insulin passport was the pharmacist’s responsibility or
another healthcare professional’s such as a diabetic spe-
cialist nurse. In contrast, the steroid card was perceived
as a clinical process that is part of the pharmacist’s role
as is specified as a requirement in the BNF. The medi-
cines helpline card and the steroid card have been im-
plemented for more than 20 years and seem established
in the pharmacy staff ’s dispensing role. While the medi-
cines helpline card is recommended to be given to all
discharged patients, the MMP is left to professional dis-
cretion and judgement by the pharmacist or technician,
introducing an inherent lack of standardisation. The per-
ceived low implementation of the medication passport
and insulin passport is in agreement with the study by
Dharas and Franklin [1], which found that only one ad-
mitted patient of 144 brought MMP into hospital during
the study period [1]. However, Barber et al. [11] found
that more than half of patients who had received an
MMP and agreed to take part in a telephone interview
had used it and found it useful. This contrasts with the
view of the pharmacists in our study who perceived the
MMP to be useful only in a small group of patients and
that others will not use it. This may reflect the fact
that either pharmacists make good judgments about
who should receive the MMP or it may indicate that
patients find the MMP more helpful than the phar-
macy staff believe. There was strong agreement
among the participants in this study that newer tools
(MMP and the insulin passport) need much more in-
put in terms of pharmacists’ and patients’ education
than older tools such as the warfarin yellow booklet,
the anticoagulant alert cards and the medicines help-
line card.
Strengths and limitations
This study is the first to evaluate the implementation of
patient handheld medication information using a psy-
chological framework. In addition, six tools were com-
pared, whereas previous studies evaluated only one tool
per study. Another strength was that we were able to re-
cruit a wide range of pharmacy staff including pharma-
cists and pharmacy technicians. Although we had
originally planned to use purposive sampling, practical
constraints meant that a convenience sample had to be
used, and only two pharmacy technicians were able to
participate. Other limitations are that we did not collect
data about participants’ age and work experience, that
we were not able to triangulate our findings with quanti-
tative implementation data and that the study was con-
ducted at one hospital organisation. Conducting another
larger study among other hospitals may provide cumula-
tive validity and more generalisability.
Recommendations
General recommendations
Hospital organisations should formulate guidance to
specify those patients who should receive which tool.
This could include criteria for issuing a tool in terms of
the treatment being received by the patient and other
patient characteristics. It would be helpful if tools were
also available in different languages. Hospital organisa-
tions may need to increase the awareness among health-
care professionals of the availability of different tools
such as through posters and training sessions, in order
to include them in consultations and in patient and fam-
ily education.
Recommendations for the specific tools
Printing MMP in a smaller format, to fit patients’
pockets, may be useful. Also, as some participants found
difficulty in folding the insulin passport, changing its de-
sign into a booklet might assist pharmacy staff and/or
patients to complete it. Modernising the design and lay-
out of the steroid card might encourage patients to use
it more often and raise its profile among pharmacy staff.
It would be useful to have a single tool that combines
the functions of two or more tools for patients on two
or more high-risk medications, instead of having to carry
more than one.
Conclusion
The main facilitators to the implementation of the
widely implemented tools such as the warfarin yellow
booklet and the steroid were that they had been inte-
grated into SOPs and training at local and/or national
level. On the other hand, the newer tools did not have
these facilitators and participants reported that they
were less widely implemented. Integration of patient
handheld tools into SOPs may improve patient safety
across healthcare settings.
Appendix
Interview guide
My name is Tasneem Waly. Thank you for agreeing
to take part in this interview. I am speaking to phar-
macy staff to understand what are the barriers and fa-
cilitators to the implementation of patient hand held
medication cards and records from their perspective.
I am interested in your thoughts and opinions; there
are no right or wrong answers. With your permission
I would like to record this interview. This is so that I
can concentrate on what you are saying rather than
writing it down. I will then type this up and remove
any information that identifies you personally. If you
would like to stop the recording at any point, or skip
questions or take a break please let me know. I will
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ask you 10 questions, which will take approximately
20-30 minutes. Do you have any questions? Is it ok if
we begin now?
To what extent do you think My Medication passport is
implemented?
Prompts:
 Can you give me more details about that?
Probes:
 Could you tell me a bit more about that? Why is
that?
 Can you give me an example of that?
A) What may prompt you to offer it to a
patient?
B) What might prevent you from offering it to a
patient?
C) What might be the general facilitators to its
implementation?
D) What might be the general barriers to its
implementation
1. To what extent do you think the steroid card is
implemented?
Prompts:
 Can you give me more details about that?
Probes:
 Could you tell me a bit more about that? Why is
that?
 Can you give me an example of that?
A) What may prompt you to offer it to a
patient?
B) What might prevent you from offering it to a
patient?
C) What might be the general facilitators to its
implementation?
D) What might be the general barriers to its
implementation?
2. To what extent do you think the insulin
passport is implemented?
Prompts:
 Can you give me more details about that?
Probes:
 Could you tell me a bit more about that? Why is
that?
 Can you give me an example of that?
A) What may prompt you to offer it to a
patient?
B) What might prevent you from offering it to a
patient?
C) What might be the general facilitators
regarding its implementation?
D) What might be the general barriers to its
implementation?
3. To what extent do you think the oral anti-
coagulant booklet and the alert cards are
implemented?
Prompts:
 Can you give me more details about that?
Probes:
 Could you tell me a bit more about that? Why is
that?
 Can you give me an example of that?
A) What may prompt you to offer it to a
patient?
B) What might prevent you from offering it to a
patient?
C) What might be the general facilitators to its
implementation?
D) What might be the general barriers to its
implementation?
4. To what extent do you think the medication
helpline card is implemented?
Prompts:
 Can you give me more details about that?
Probes:
 Could you tell me a bit more about that? Why is
that?
 Can you give me an example of that?
A) What may prompt you to offer it to a
patient?
B) What might prevent you from offering it to a
patient?
C) What might be the general facilitators to its
implementation?
D) What might be the general barriers to its
implementation?
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5. What are the differences in implementation of
different patient handheld medication cards
and records?
Prompts:
 Why is that?
 What other things that could have impacted their
implementation?
Probes:
 Could you tell me a bit more about that? Why is
that?
 Can you give me an example of that?
6. What are the challenges that are faced by
pharmacists and pharmacy technicians in
implementing these interventions?
Prompts:
 Can you describe those challenges in details?
Probes:
 Can you give me an example of that?
7. In which type of patients are those
interventions difficult to implement?
Prompts:
 Can you describe those difficulties?
Probes:
 Could you tell me a bit more about that? Why is
that?
 Can you give me an example of that?
8. How could implementation of these
interventions be increased?
Prompts:
 What types of things can healthcare professionals do
to improve the implementation of those
interventions
 What types of things can organizational bodies
improve the implementation of these interventions?
Probes:
 Can you tell me more about that? Why is that?
 Can you give me an example of that?
9. Is there anything about implementation barriers
that we have not spoken about yet?
Thank you for taking part in this interview. Do you
have any questions you would like to ask? Is there any-
thing you would like to explain?
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